2026-03-30
NEW YORK, April 30, 2025 – In a significant development for biomedical research, Mantis Biotech is pioneering digital twin technology to address one.
NEW YORK, April 30, 2025 – In a significant development for biomedical research, Mantis Biotech is pioneering digital twin technology to address one.
DOHA, Qatar – February 2025: Thousands of rare diseases remain untreated despite modern biotechnology’s gene-editing capabilities and drug design tools. The pharmaceutical industry.
In the high-stakes arena of pharmaceutical research, a new contender has emerged with breathtaking speed. Chai Discovery, an AI biotech startup founded in.
In a move that underscores the accelerating convergence of artificial intelligence and human biology, OpenAI has made a significant strategic investment in Merge.
In a significant move that underscores the accelerating fusion of artificial intelligence and life sciences, Boston- and Tel Aviv-based startup Converge Bio announced.
Imagine a world where blindness can be reversed with an implant smaller than a grain of rice. This isn’t science fiction—it’s the reality.
In a surprising and significant move, 180 Life Sciences (Nasdaq: ATNF), a prominent biotechnology company also known by the intriguing moniker “ETHZilla,” recently.
The convergence of traditional finance and the dynamic world of digital assets is accelerating, exemplified by a truly groundbreaking announcement. 180 Life Sciences,.